title: Clinical and epidemiological characteristics of children with Kawasaki disease in Turkey.
abstract: BACKGROUND
  Kawasaki disease (KD) is the leading cause of acquired heart disease in childhood in the developed countries. The objective of this study is to describe the clinical and epidemiological characteristics of children with KD in Turkey.
  
  
  METHODS
  The medical records of 24 patients treated for KD between January 1994 and June 2009 at Ankara University Medical School, Turkey were reviewed.
  
  
  RESULTS
  The male-to-female ratio was 1.4 : 1. The median age at diagnosis was 2 years (range: 6.5 months to 11 years). Conjunctivitis and changes in the lips and oral cavity were seen in 21/24 (87.5%), cervical lymphadenopathy 17/24 (70.8%), polymorphous rash 16/24 (66.7%) and peripheral changes in 12/24 (50%). Coronary artery abnormality (CAA) was observed in 8/24 (33.3%) cases. CAA was seen in both the complete and incomplete groups with similar frequency (31.3% vs. 37.5%, respectively).
  
  
  CONCLUSIONS
  KD must be kept in mind in the differential diagnosis of infants with prolonged fever.
authors.affiliation: Department of Pediatrics, Ankara University Medical School, Dikimevi, Ankara, Turkey. doktorhalil@gmail.com
authors.forename: Halil
authors.initials: H
authors.lastname: Ozdemir
authors.forename: Ergin
authors.initials: E
authors.lastname: Ciftçi
authors.forename: Anil
authors.initials: A
authors.lastname: Tapisiz
authors.forename: Erdal
authors.initials: E
authors.lastname: Ince
authors.forename: Ercan
authors.initials: E
authors.lastname: Tutar
authors.forename: Semra
authors.initials: S
authors.lastname: Atalay
authors.forename: Ulker
authors.initials: U
authors.lastname: Dogru
mesh_terms: D017677:Age Distribution; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D001241:Aspirin / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D005260:Female; D005334:Fever / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage*; D007155:Immunologic Factors / Q000008:administration & dosage*; D015994:Incidence; D007223:Infant; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D012737:Sex Factors; D016896:Treatment Outcome; D014421:Turkey / Q000453:epidemiology; D014657:Vasculitis / Q000453:epidemiology / Q000209:etiology
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D001241:Aspirin